ARYA Sciences Acquisition IV (ARYD) Terminates Caritas Deal
ARYA IV (NASDAQ:ARYD) has agreed to mutually terminate its combination with the gene therapy division of biotech firm Amicus (NASDAQ:FOLD).
The news came not from ARYA IV’s end but as a part of Amicus’ quarterly updates and it primarily blamed “unfavorable market conditions affecting IPOs, follow-on financings and SPACs”. ...READ MORE
